GlassScriptPrepare for your visit
David Michael Tadin
Interventional Cardiology · Lafayette, LA · NPI 1508131814
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$11,008.16
in general payments reported to CMS, 2019-2025 · $1,450 in 2025
The $1,450 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Who reported paying
General payments only, top 6 by amount.
- Abiomed $1,553.75
- Penumbra, INC. $1,363.68
- Boston Scientific Corporation $797.73
- Novartis Pharmaceuticals Corporation $731.54
- Cardiovascular Systems INC. $650.48
- Angiodynamics, INC. $649.26
Drugs and devices associated with these payments
Impella Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter Auryon Laser System 100-120 Vac Camzyos Leqvio Eliquis Ranger Alphavac Entresto Lifevest Ozempic Onpattro
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw David Tadin listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/1380291/david-michael-tadin